Clinical Trials
18 trialsNCT02071901 2021-12-01
Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy
Case Comprehensive Cancer Center
Phase 2 Unknown
NCT04687657 2021-08-24
Umbilical Cord Blood Transfusion in Consolidation Therapy of Elderly Patients With Acute Myeloid Leukemia
First Affiliated Hospital Xi'an Jiaotong University
Phase 1 Unknown
NCT00651261 2021-08-18
Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Alliance for Clinical Trials in Oncology
Phase 3 Unknown
NCT00898092 2021-08-17
Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia
Alliance for Clinical Trials in Oncology
Unknown
NCT04803929 2021-03-23
Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5)
Carbiogene Therapeutics Co. Ltd.
Phase EARLY_PHASE1 Unknown
NCT00354276 2014-01-10
VNP40101M Followed by Cytarabine in Treating Older Patients With Acute Myeloid Leukemia
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00454168 2014-01-06
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00002658 2013-12-19
Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00006084 2013-12-19
Monoclonal Antibody in Treating Patients With Acute Myelogenous Leukemia
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00006045 2013-11-06
Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00544999 2013-09-17
Everolimus, Cytarabine, and Daunorubicin in Treating Patients With Relapsed Acute Myeloid Leukemia
National Cancer Institute (NCI)
Phase 1 Unknown
NCT01421862 2013-07-10
Biomarkers in Samples From Adult Patients With Acute Myeloid Leukemia Who Failed Existing Standard-of-Care Treatment
National Cancer Institute (NCI)
Unknown
NCT00091234 2012-07-24
AML-19
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2/3 Unknown
NCT00838240 2012-07-20
AML-14A
European Organisation for Research and Treatment of Cancer - EORTC
Phase 1/2 Unknown
NCT00002549 2009-12-23
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00004128 2009-12-23
Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00799799 2009-09-24
Adoptive Immunotherapy of High Risk Acute Myeloblastic Leukemia Patients Using Haploidentical Kir Ligand-mismatched Natural Killer Cells
University of Bologna
Phase 1 Unknown
NCT00003758 2009-02-09
Combination Chemotherapy in Treating Patients With Relapsed Acute Myelogenous Leukemia
National Cancer Institute (NCI)
Phase 2 Unknown